Eckhardt Weber
Co-Founder and Managing Partner @ Heal Capital
Berlin, Germany
Eckhardt Weber is a seed investor at Heal Capital in Berlin focused on Health Care and Medical. Eckhardt Weber is Managing Partner at heal capital. He attended Ludwig-Maximilians-Universität München.
- Total investments:
- 18
- Last investment:
- Lead investor:
- 61%
Last updated:
For AI agents: llms.txt
Industries Eckhardt Weber invests in
Stages Eckhardt Weber invests in
Countries Eckhardt Weber invests in
Investment Focus
Industry
- Health Care 6 (33%)
- Medical 3 (17%)
- Biotechnology 2 (11%)
- Pharmaceutical 2 (11%)
- Personal Health 2 (11%)
Stage
- Seed 7 (39%)
- Series A 4 (22%)
- Pre-Seed 3 (17%)
- Angel 1 (6%)
- Series B 1 (6%)
Country
- Germany 9 (50%)
- United Kingdom 2 (11%)
- Canada 1 (6%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Paloma Health
|
A technology-enabled provider of children's mental health services, starting with autism assessments. | $4M / Pre-Seed / Jul 15, 2025 | |
Apheris
|
apheris AI was founded by Robin Rohm and Michael Höh with a shared dream to empower companies to run analytics on decentralized datasets. Michael developed software infrastructure for distributed data during his PhD at Forschungszentrum Julich and his time at BCG. Robin has a background in algebraic theories for data linkage and data privacy andhas experienced the complexity of centralizing sensitive personal healthcare data firsthand in one of his previous start-ups. Through their work, they encountered barriers that limit progress within data driven industries: data is often stored in silos and most companies work in closed data ecosystems. Therefore, Apheris strives to connect the world’s data to extract better insights. | $20.8M / Series A / Jan 02, 2025 | |
|
Paloma Health
|
A technology-enabled provider of children's mental health services, starting with autism assessments. | $2.6M / Pre-Seed / Nov 11, 2024 | |
Parto
|
Parto services include business accounts, accounts with fiduciary custody, and payment cards for staff members and those receiving care. Using our proprietary software, which allows for automated billing of business expenses and digital custody fund administration. | $2.7M / Pre-Seed / Oct 15, 2024 | |
Sanvivo
|
Sanvivo creates a multifaceted website that lets users acquire prescription drugs, get pharmacy guidance, and reserve medical services from nearby pharmacies. | $1M / Seed / May 16, 2023 | |
|
Apheris
|
apheris AI was founded by Robin Rohm and Michael Höh with a shared dream to empower companies to run analytics on decentralized datasets. Michael developed software infrastructure for distributed data during his PhD at Forschungszentrum Julich and his time at BCG. Robin has a background in algebraic theories for data linkage and data privacy andhas experienced the complexity of centralizing sensitive personal healthcare data firsthand in one of his previous start-ups. Through their work, they encountered barriers that limit progress within data driven industries: data is often stored in silos and most companies work in closed data ecosystems. Therefore, Apheris strives to connect the world’s data to extract better insights. | $8.7M / Seed / Nov 07, 2022 | |
Entyre
|
Entyre solutions are based on proprietary data and algorithms and allow patients, doctors, and insurance companies to make better decisions. It helps to provide technical solutions to identify and correct incorrect supplies. For inquiries, email, telephone numbers, and physical addresses are available on their website. | Series A / Nov 07, 2022 | |
Avi Medical
|
Avi Medical is a digital health care company that provides telemedicine services. Its platform enables patients to book appointments, manage their health data, and chat with the practitioner. The company uses data-driven medicine to provide patients and healthcare workers with a streamlined, more modern experience. | $54.5M / Series B / Apr 06, 2022 | |
Sanome
|
Sanome are combining different types of biomarkers to develop engaging, useful and accurate diagnostic products (IVDs) that enable early detection and prevention of disease. The IVD innovation engine, will ultimately enable new approaches for healthcare delivery, providing access to novel at-home testing paradigms for all people. | $2.5M / Pre-Seed / Sep 28, 2021 | |
|
Avi Medical
|
Avi Medical is a digital health care company that provides telemedicine services. Its platform enables patients to book appointments, manage their health data, and chat with the practitioner. The company uses data-driven medicine to provide patients and healthcare workers with a streamlined, more modern experience. | $34.7M / Series A / Jun 07, 2021 | |
| See all 18 investments → | |||
Co-Investors
About Heal Capital
Heal Capital is one of Europe’s leading dedicated investment funds for HealthTech with a total investment volume of over EUR 200m, backed by the healthcare institutions We back mission-driven founders with capital and HealthTech-specific expertise, accelerating market access to the healthcare system. Our investment focus is pre-seed to Series A.
Heal Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Eckhardt Weber
Co-Founder and Managing Partner
|
|||
Christian Lautner
Managing Partner
|
|||
Lucas Mittelmeier
Investment Professional
|
|||
Markus Müschenich
Founding Partner
|
|||
Marta Michniewicz
Platform Manager
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Eckhardt Weber invest in?
Eckhardt Weber invests primarily in Health Care, Medical and Biotechnology startups, most often at Seed and Series A stage. Most of the 18 investments tracked by Shizune back companies in Germany. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Eckhardt Weber last invest?
The most recent investment recorded for Eckhardt Weber closed in Jul 2025. Shizune tracks 18 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
